Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it made a number of changes on its board of directors.
Dublin, Ohio-based Navidea ‘s chair of the board and director S. Kathryn Rouan, along with director Claudine Bruck, retired from those positions, effective immediately.
Get the full story at our sister site, Drug Delivery Business News.